Search

Your search keyword '"Larenas-Linnemann, Désirée E"' showing total 137 results

Search Constraints

Start Over You searched for: Author "Larenas-Linnemann, Désirée E" Remove constraint Author: "Larenas-Linnemann, Désirée E"
137 results on '"Larenas-Linnemann, Désirée E"'

Search Results

1. Impact of Allergic Rhinitis Control on Work Productivity and Costs: A Real-World Data MASK-air Study

2. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)

3. MASK-air: An OECD (Organisation for Economic Co-operation and Development) Best Practice for Public Health on Integrated Care for Chronic Diseases

4. Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study

5. Cutoff Values of MASK-air Patient-Reported Outcome Measures

6. The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis

7. Poor rhinitis and asthma control is associated with decreased health-related quality-of-life and utilities: A MASK-air study

8. MASK-air®: An OECD (Organisation for Economic Coordination and Development) Best Practice for Public Health on integrated care for chronic diseases.

9. The Role of Mobile Health Technologies in Stratifying Patients for AIT and Its Cessation: The ARIA-EAACI Perspective

10. Digitally‐enabled, person‐centred care (PCC) in allergen immunotherapy: An ARIA‐EAACI Position Paper.

11. Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma

12. Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper

13. Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA‐EAACI approach – ARIA‐EAACI Task Force Report

14. Asthma and rhinitis control in adolescents and young adults: A real‐world MASK‐air study.

15. Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air approach.

16. Consistent trajectories of rhinitis control and treatment in 16,177 weeks : the MASK-air® longitudinal study

17. Patient-centered digital biomarkers for allergic respiratory diseases and asthma:The ARIA-EAACI approach – ARIA-EAACI Task Force Report

18. Patient‐centred digital biomarkers for allergic respiratory diseases and asthma: the ARIA‐EAACI approach

19. Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air ® approach

20. Consistent trajectories of rhinitis control and treatment in 16,177 weeks

21. MASK‐air® direct patient data support the ARIA‐MeDALL hypothesis on allergic phenotypes.

22. Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air ® approach

23. The ARIA-MASK-air® approach

24. A study using MASK-air® real-world data

25. Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK‐air® longitudinal study

26. Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities

28. Results of a Bayesian mixed-effects model

29. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air real-world data.

30. Development and validation of combined symptom-medication scores for allergic rhinitis*

31. Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study.

32. Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities

33. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

34. Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK‐air® longitudinal study.

35. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air ® real‐world data

36. Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model

37. Development and validation of combined symptom‐medication scores for allergic rhinitis*

38. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK‐air®

39. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice

40. Digital transformation of health and care in airway diseases from research to practice

41. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®

43. Coronavirus disease 2019, allergic diseases, and allergen immunotherapy: Possible favorable mechanisms of interaction

44. ARIA digital anamorphosis:Digital transformation of health and care in airway diseases from research to practice

46. Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19

47. Spices to Control COVID-19 Symptoms: Yes, but Not Only…

48. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice

50. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

Catalog

Books, media, physical & digital resources